Moody National Bank Trust Division Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Moody National Bank Trust Division grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 5.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 8,643 shares of the medical equipment provider’s stock after acquiring an additional 435 shares during the period. Moody National Bank Trust Division’s holdings in Intuitive Surgical were worth $2,293,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ISRG. RB Capital Management LLC raised its position in shares of Intuitive Surgical by 4.4% in the 1st quarter. RB Capital Management LLC now owns 1,735 shares of the medical equipment provider’s stock worth $523,000 after acquiring an additional 73 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Intuitive Surgical by 0.6% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 946,709 shares of the medical equipment provider’s stock worth $285,603,000 after acquiring an additional 5,233 shares in the last quarter. Baird Financial Group Inc. raised its position in shares of Intuitive Surgical by 2.3% in the 1st quarter. Baird Financial Group Inc. now owns 21,089 shares of the medical equipment provider’s stock worth $6,362,000 after acquiring an additional 481 shares in the last quarter. Brown Brothers Harriman & Co. raised its position in shares of Intuitive Surgical by 576.7% in the 1st quarter. Brown Brothers Harriman & Co. now owns 406 shares of the medical equipment provider’s stock worth $122,000 after acquiring an additional 346 shares in the last quarter. Finally, Covestor Ltd raised its position in shares of Intuitive Surgical by 50.4% in the 1st quarter. Covestor Ltd now owns 418 shares of the medical equipment provider’s stock worth $126,000 after acquiring an additional 140 shares in the last quarter. Institutional investors own 81.96% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded down $2.70 on Friday, reaching $237.80. The stock had a trading volume of 2,304,603 shares, compared to its average volume of 1,726,326. The stock has a market cap of $83.29 billion, a P/E ratio of 64.97, a price-to-earnings-growth ratio of 4.68 and a beta of 1.29. Intuitive Surgical, Inc. has a 1 year low of $180.07 and a 1 year high of $308.97. The company has a 50 day simple moving average of $244.17 and a 200 day simple moving average of $238.15.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its quarterly earnings results on Tuesday, January 24th. The medical equipment provider reported $1.23 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.25 by ($0.02). The firm had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.66 billion. Intuitive Surgical had a return on equity of 11.27% and a net margin of 21.25%. The business’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the business earned $1.30 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 4.21 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of analyst reports. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $250.00 to $280.00 and gave the company an “overweight” rating in a research report on Friday, November 18th. Raymond James raised their price objective on Intuitive Surgical from $255.00 to $270.00 and gave the company an “outperform” rating in a research report on Thursday, January 26th. Deutsche Bank Aktiengesellschaft raised their price objective on Intuitive Surgical from $230.00 to $245.00 in a research report on Wednesday, January 25th. Morgan Stanley reduced their price objective on Intuitive Surgical from $290.00 to $265.00 and set an “equal weight” rating for the company in a research report on Wednesday, January 25th. Finally, Truist Financial reduced their price objective on Intuitive Surgical from $310.00 to $300.00 and set a “buy” rating for the company in a research report on Wednesday, January 25th. Six analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $273.83.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP David J. Rosa sold 45,025 shares of the firm’s stock in a transaction dated Monday, February 6th. The stock was sold at an average price of $250.53, for a total transaction of $11,280,113.25. Following the sale, the executive vice president now directly owns 125,385 shares of the company’s stock, valued at $31,412,704.05. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 1,629 shares of the firm’s stock in a transaction dated Friday, January 27th. The stock was sold at an average price of $250.00, for a total transaction of $407,250.00. Following the sale, the executive vice president now directly owns 6,769 shares of the company’s stock, valued at $1,692,250. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP David J. Rosa sold 45,025 shares of the firm’s stock in a transaction dated Monday, February 6th. The shares were sold at an average price of $250.53, for a total value of $11,280,113.25. Following the sale, the executive vice president now directly owns 125,385 shares in the company, valued at $31,412,704.05. The disclosure for this sale can be found here. Over the last three months, insiders have sold 82,396 shares of company stock worth $20,438,478. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

(Get Rating)

Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.